​

Funding Round

Pre Seed Round - Meddenovo Drug Design

Pre Seed Round - Meddenovo Drug Design

Investment Firm

Overview

Leading AI-driven drug design, specializing in high-tech molecular modelling with a focus on cyclic peptide therapeutics.

Announced Date

Jul 31, 2024

Funding Type

Pre Seed

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

ACT Venture Partners

ACT Venture Partners

ACT Venture Partners is a convertible_note and early_stage_venture and seed firm.

Participant Investors

1

Investor Name
Participant InvestorACT Venture Partners

Round Details and Background

Meddenovo Drug Design raised $1082532 on 2024-07-31 in Pre Seed Round

Leading AI-driven drug design, specializing in high-tech molecular modelling with a focus on cyclic peptide therapeutics.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 31, 2024
Pre Seed Round - Meddenovo Drug Design
1-1.1M

Recent Activity

There is no recent news or activity for this profile.